Jul 28, 2025 3-5pm ET
Monday on The Robert Scott Bell Show:
Hour 1
Exposing the Lie That Antidepressant Withdrawal Symptoms Are Mild and Short‑Lived A recent systematic review highlighted by the author reveals a widespread and dangerous misconception: that antidepressant withdrawal symptoms are generally mild and brief. Despite official narratives downplaying the issue, the review in JAMA Psychiatry challenges the claim that post‑discontinuation depression is relapse rather than withdrawal, noting that withdrawal effects are frequently mistaken for the return of illness. The author underscores data showing that tens of millions globally who take antidepressants experience substantial and often long-lasting symptoms when attempting to stop. These reactions—sometimes termed “abstinence depression”—can include flu‑like sensations, brain zaps, mood swings, anxiety, insomnia, and suicidal thoughts. Prevalence estimates suggest that roughly half of patients will suffer withdrawal symptoms, with about 25 million facing severe illness during tapering. Current clinical guidelines, shaped by selective interpretations of short-term trials and influenced by pharmaceutical interests, mislead patients and clinicians and offer inadequate tapering protocols. Firsthand patient accounts, particularly from large-scale community surveys, recount crippling symptoms that health systems frequently fail to recognize or treat effectively. The article calls for urgent reform in psychiatric practice, including clearer prescriber education, more gradual tapering schedules, informed consent, and independent patient monitoring. It also advocates for broader acknowledgment in professional training that withdrawal, not relapse, often drives post-treatment setbacks. Ultimately, the piece warns that perpetuating this lie perpetuates harm, undermines trust in mental health care, and obstructs patient autonomy and wellness.
Courts Banned This Herbicide Twice. The EPA Wants to Bring It Back. The EPA has proposed re-approving dicamba, a widely used herbicide, for use on genetically engineered cotton and soybean crops—despite federal courts vacating its registration twice, in 2020 and 2024. The courts found that prior approvals failed to adequately assess risks associated with drift and environmental impact. Dicamba is known for volatilizing and damaging non-target crops and wild flora, often injuring neighboring farmland and upsetting ecological balance. Environmental groups and small-farm advocates, who sued the agency in past rulings, are preparing new legal challenges. While the EPA asserts the chemical poses no significant human health risk and emphasizes new application guidelines to limit harm, critics argue that these protections are insufficient. They warn that the re-approval—if finalized—would institutionalize a high-risk pesticide whose track record includes widespread crop loss, ecological disruption, and legal disputes. The announcement has reignited concerns over regulatory capture, with critics pointing to the agency’s engagement with pesticide manufacturers and lobbyists. Public comment is open for 30 days, initiating the next legal and policy battleground. The article situates this move within a pattern of regulatory rollback and erosion of precautionary standards in U.S. pesticide regulation, raising questions about long-term agricultural health and community safety.
Congress Sells Out Consumers in Chemical Industry Giveaway Congress is considering legislation that critics argue would significantly weaken consumer protections and consolidate chemical industry power. The proposed Markey‑Booker bill would dismantle the established “Generally Recognized As Safe” (GRAS) framework, effectively eliminating self-regulation for over ten thousand food additives and ingredients. Instead of allowing companies to affirm safety independently, the bill would require burdensome pre-market notifications and FDA approval, potentially triggering regulatory gridlock. Simultaneously, the Food Chemical Reassessment Act, introduced by Schakowsky and DeLauro, demands mandatory reassessments of selected additives every three years. While this seems consumer-friendly, critics warn that the legislation would empower industry to cement grandfathered uses and limit liability, while clogging the FDA with unmanageable mandates—allowing truly hazardous additives to persist under bureaucratic overload. Combined, the bills would shift regulatory authority, freeze innovation, and grant undue influence to large chemical players. Public interest advocates argue that the current GRAS model strikes a balance between consumer access to safe ingredients and government oversight, and that replacing it with a centralized system is neither practical nor protective. They call for targeted reform focused on transparency and risk-based review—not wholesale loss of consumer autonomy. The legislation threatens supplement access, homeopathic remedies, and natural products by imposing new procedural barriers under the guise of safety, all while benefitting entrenched chemical firms at consumer expense.
New Bills Threaten Supplement Access: Take Action Now! New legislation moving through Congress poses a direct threat to the availability of dietary supplements and natural health products, according to the Alliance for Natural Health. The bills in question—especially the so-called “supplement registration” measures—would give the FDA expanded authority to require mandatory product listings, effectively creating a pre-approval system for all dietary supplements. Critics argue that this shifts the burden of proof from regulators to producers, and could allow the FDA to arbitrarily remove supplements from the market under the pretense of safety review. The proposed rules also include vague language about “new dietary ingredients,” which would restrict innovation by forcing companies to undergo a costly approval process even for long-used natural compounds. Advocates warn that these bills echo the pharmaceutical industry’s desire to tighten control over non-patented, plant-based, and nutrient-dense products that compete with drugs. In practice, this would undermine access to vitamins, minerals, herbs, and probiotics—many of which consumers rely on for preventive care and chronic condition management. The article emphasizes that this legislative push is not about ensuring public safety, as supplements already maintain an outstanding safety record, but rather about consolidating regulatory control. Citizens are urged to contact their legislators immediately to oppose the bills and defend health freedom. The window for public action is closing, and failure to resist now could permanently change the landscape of natural health access in the United States.
Welcome back to another “Homeopathic Hits” episode on The Robert Scott Bell Show!
Today we spotlight Inula Helenium, also known as Elecampane—a towering herbal ally with golden blossoms and a history as rich as its earthy aroma.
Traditionally used to soothe coughs and respiratory distress, this remedy digs deep into the bronchial tubes, sinuses, and digestive tract to ease congestion and revitalize lung function. Named after Helen of Troy, it’s the stuff of legends—for your lungs.
Download the Information Sheet
Hour 2
Welcome to the Revolution The article announces the launch of the MAHA Revolution, celebrating the rebranding of AV24 into MAHA PAC and marking a pivotal moment in the movement for health freedom and ecological accountability. The event took place on July 21 and featured immersive presentations that emphasized community, direct action, and collective activism. Speakers highlighted MAHA’s transformative role in shifting from traditional partisan politics to a unifying platform centered on holistic health, environmental justice, and democratic engagement. The piece underscores how MAHA disrupts the wellness industry’s corporate associations by reclaiming grassroots spirituality and local healing practices. It presents the movement as an antidote to centralized allopathic paradigms, framing MAHA as a revival of empowered civic sovereignty rooted in natural law and spiritual consciousness. Attention is given to the emotional resonance of the gathering as an opening act for broader nation-wide mobilization, with emphasis on coalition-building and cross-sector allies. The article positions this as not just political organizing but cultural regeneration, where personal healing, ecological restoration, and systemic change are inseparable. It concludes with a call to action, inviting sympathetic citizens to “join the revolution” by aligning their lives with MAHA’s principles of health justice, individual agency, and collective regeneration.
‘Not going anywhere’: Mosquitoes thrive in Las Vegas, gain pesticide immunity Unrelenting summer heat has not deterred mosquito populations in Las Vegas; instead, researchers report that mosquito species—especially Aedes aegypti and Culex quinquefasciatus—are thriving and developing resistance to common pesticides. Testing by UNLV’s Parasitology & Vector Biology Laboratory found survival at concentrations up to 100 times greater than standard application rates. Mosquitoes collected near stagnant water on golf courses and residential areas consistently exhibit toxin immunity. Public health officials warn that pesticide resistance exacerbates the city’s disease risk management, as these insects are capable of spreading West Nile virus and potentially dengue, chikungunya, yellow fever, or Zika. Though no arboviral infections in mosquitoes or humans have been detected as of mid-July, authorities caution that late-season outbreaks remain possible. Experts emphasize the importance of coordinated abatement efforts—targeting neglected sources like stagnant pools or uncontrolled standing water—to prevent resurgence. Without collective action across jurisdictions, isolated efforts fail and mosquitos continue seeding communities. The story highlights rising ecological pressures and evolving vector resilience, calling for integrated control strategies that anticipate adaptive resistance and prioritize public health prevention before disease transmission begins.
Scientists use dental floss to deliver vaccines without needles Researchers have pioneered a novel, needle-free vaccine delivery method that uses specially coated dental floss to administer flu antigens through the gumline. Published in Nature Biomedical Engineering, the proof-of-concept study showed that mice flossed with inactive flu virus applied to the junctional epithelium between teeth and gums developed robust systemic and mucosal immunity. Following exposure to a lethal flu strain, all vaccinated mice survived while unvaccinated controls died. Evidence of antibody production in saliva, feces, and bone marrow signals an effective, multi-site immune response. Human feasibility testing using dye-coated floss demonstrated successful delivery of molecules to the gum epithelium in over half of volunteers. The approach depends on the gum’s natural permeability and immune activation ability, opening a potential pathway for pain-free, easily distributed vaccination in low-resource settings or emergency outbreaks. This method could revolutionize vaccine accessibility by eliminating needle barriers, lowering deployment barriers, and enabling postal distribution. Researchers plan to validate the technique in larger animals before initiating human trials. While early, the innovation promises a significant step toward more equitable and scalable immunization strategies.
Peter Hotez PANICS After Heavily‑Vaxxed Caller Reveals “Worst Experience Ever” Post‑Booster During a media appearance on “Hello Houston,” vaccine advocate Dr. Peter Hotez faced an unexpected confrontation when a heavily boosted listener named Carol called in to describe what she termed the “worst experience ever” two days after her last COVID-19 booster. Carol reported sleeping 16 hours a day and suffering a persistent, phlegm-filled cough, despite never having had COVID. Hotez initially attributed her condition to a possible unrelated viral infection. As Carol emphasized her severe symptoms, Hotez acknowledged the possibility of a vaccine side effect but quickly redirected the explanation to alternative illnesses. Observers noted that this moment marked a rare public acknowledgment of potential vaccine-related injury in real time. The exchange sparked controversy, with critics arguing Hotez deflected immediate accountability. Supporters of Carol’s account viewed the episode as significant validation for those reporting post-vaccine health issues. The article suggests Hotez’s response reflects a broader hesitance within public health advocacy to directly confront vaccine injury claims, even as anecdotal reports continue to mount. No independent medical verification of Carol’s symptoms or timeline is available, but the live interaction prompted intense online debate. The story underscores questions about medical authority, transparency in vaccine communication, and the treatment of patient-reported adverse events in public discourse.
Moderna’s Parent Company Now Spraying RNA Into Your Food Flagship Pioneering, the biotech incubator behind Moderna, has launched Terrana Biosciences—a company developing sprayable synthetic RNAs engineered to enter plant systems, persist under environmental stress, and potentially transmit traits across generations. RNA constructs are developed using artificial intelligence models and a vast digital library of sequences. The company aims to transform agriculture with precise, adaptive biologics intended to enhance crop resilience and yield without altering DNA. Critics argue the technology represents a dangerous shift toward genetic modification via environmental exposure. They voice concerns that aerosol or agricultural spraying of RNA could become a stealth vector, blurring lines between biotech intervention and food contamination. Flagship’s founder and CEO Noubar Afeyan, who co-founded Moderna, has close ties to federal health agencies, raising alarms among watchdog groups about coordination between human vaccine infrastructure and environmental RNA deployment. While Terrana presents the technology as a safer alternative to traditional chemical pesticides, the article frames it as an unregulated experiment with potential long‑term ecological and health implications. The campaign warns of coordinated plans to aerosolize gene therapies or synthetic immunity agents across humans and animals, referencing historical speculation over emergency authorization powers. The work raises urgent questions about future biotech oversight: how machine-designed synthetic RNA sprayed into the food system could redefine pharmaceutical reach into agriculture, food sovereignty, and consumer choice.
Remember Friends, The Power to Heal is Yours!
